VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MAN
- 10 February 1979
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 313 (8111), 325-326
- https://doi.org/10.1016/s0140-6736(79)90737-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- VIRUS ANTIBODIES IN SERUM SPECIMENS FROM PATIENTS WITH MULTIPLE SCLEROSIS, FROM SIBLINGS, AND MATCHED CONTROLS. A FINAL REPORT*Acta Neurologica Scandinavica, 2009
- CHOLESTEROL AND IMMUNE RESPONSE TO INFLUENZA ANTIGENSThe Lancet, 1978
- PGI2 production by rat blood vessels: Diminished prostacyclin formation in veins compared to arteriesProstaglandins, 1978
- Decreased vascular prostacyclin in experimental diabetesLife Sciences, 1978
- An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclinProstaglandins, 1978
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Sex and age differences in human platelet aggregationNature, 1975
- Platelet adhesiveness and aggregation in relation to diabetic retinopathyDiabetologia, 1971
- Evaluation of the P-Toluene-Sulfonic Acid Method for Quantitative Determination of Total Cholesterol in SerumScandinavian Journal of Clinical and Laboratory Investigation, 1956